ReviewBiomedicines2026

Gemcitabine-Based Bladder Preservation in BCG-Unresponsive High-Risk NMIBC: Evidence, Limitations, and Clinical Positioning.

Aris Kaltsas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.